Artificial cell for disease transmission, artificial red blood cells are desired because they eliminate drawbacks associated with allogenic blood transfusions such as blood typing, immune reactions and its short storage life of 42 days. A hemoglobin substitute may be stored at room temperature and not under refrigeration for more than a year. Attempts have been made to develop a complete working red blood cell which comprises carbonic not only an oxygen carrier but also the enzymes associated with the cell. The first attempt was made in 1957 by replacing the red blood cell membrane by an ultrathin polymeric membrane which was followed
Neonatal red cell transfusion Neonatal red cell transfusion Neonates are defined as babies up to 28 days after birth. Most extremely preterm babies (less than 28 weeks) require at least one red cell transfusion, this is partly due to the amount of blood removed with blood samples compared to the baby's total blood volume (iatrogenic anemia) and partly due to anemia of prematurity. Most transfusions are given as small volume top-up transfusions to increase the baby's hemoglobin above a certain pre-defined level, or because the baby is unwell due to the anemia. Possible side-effects of anemia in babies can be poor growth, lethargy and